Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004:102:233-48; discussion 248-50.

Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial

William V Good  1 ; Early Treatment for Retinopathy of Prematurity Cooperative Group
Affiliations
Clinical Trial

Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial

William V Good et al. Trans Am Ophthalmol Soc. 2004.

Abstract

Purpose: To present the final results of the Early Treatment for Retinopathy of Prematurity Study.

Methods: Infants with bilateral high-risk prethreshold retinopathy of prematurity (ROP) (n = 317) had one eye randomized to early retinal ablative treatment and the fellow eye managed conventionally (control eye). In asymmetric cases (n = 84), the eye with high-risk prethreshold ROP was randomized to early or to conventional management. High risk was determined using a model based on the Cryotherapy for Retinopathy of Prematurity natural history cohort. The primary outcome was visual acuity assessed by masked testers using the Teller acuity card procedure. Structural examinations were performed at 6 and 9 months.

Results: Grating acuity results showed a reduction in unfavorable visual acuity outcomes with earlier treatment, from 19.8% to 14.3% (P < .005). Unfavorable structural outcomes were reduced from 15.6% to 9.0% (P < .001) at 9 months. Further analysis supported retinal ablative therapy for eyes with type I ROP, defined as zone I, any stage ROP with plus disease; zone I, stage 3 ROP without plus disease; or zone II, stage 2 or 3 with plus disease. The analysis supported a "wait and watch" approach to type II ROP, defined as zone I, stage 1 and 2 without plus disease, or zone II, stage 3 without plus disease. These eyes should be considered for treatment only if they progress to type I ROP or threshold.

Conclusion: Early treatment of high-risk prethreshold ROP significantly reduced unfavorable outcomes in both primary and secondary (structural) measures.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart indicating status of the 828 infants in the ETROP study who developed prethreshold retinopathy of prematurity in one or both eyes.
See this image and copyright information in PMC

References

    1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. . Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol. 2001;119:1110–1118. - PubMed
    1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. . Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol. 1988;106:471–479. - PubMed
    1. Rescan Z, Vamos R, Salacz G. Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity. J Ophthalmol Strabismus. 2003;40:204–207. - PubMed
    1. Vander JF, Handa J, McNamara JA, et al. Early treatment of posterior retinopathy of prematurity: a controlled trial. Ophthalmology 1997;104:1731–1735; discussion 1735–1736. - PubMed
    1. Good WV, Hardy RJ for the ETROP Multicenter Study Group. . The multicenter study of early treatment for retinopathy of prematurity (ETROP) [guest editorial] Ophthalmology. 2001;108:1013–1014. - PubMed

Publication types